acssart glp-1 How medications are transforming diabetes and weight loss treatment Losing weight Cardiovascular Protective Properties of GLP-1

In the STEP 3 trial of semaglutide combined with intensive lifestyle intervention (30 counseling visits across 68 weeks, including nutrition, physical activity, and other behavioral strategies, plus 8 initial weeks of meal replacements with liquid shakes, meal bars, or portion-controlled meals), individuals experienced a 16% reduction from baseline in body weight (versus 5.7% with intensive lifestyle intervention alone) [178]

Avoid high-fat foods like fried chicken or pizza, as excess fats in the blood (lipids) can actually make your plasma appear cloudy and potentially unusable for certain treatments

At 30-month follow-up, despite weight regain in all groups (WL + AT: 7.1 kg

In comparison, 88.2% of those without PCOS with a semaglutide or tirzepatide prescription had obesity and/or diabetes